Invasive pulmonary Aspergillosis in patients with chronic obstructive pulmonary disease: An emerging fungal disease

Current Infectious Disease Reports

Volumn 12, Issue 6, 2010, Pages 409-416

  Ader, Florence ^a,b  

^a CROIX ROUSSE HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Aspergillus; Chronic obstructive pulmonary disease; Corticosteroids; Invasive pulmonary aspergillosis

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CORTICOSTEROID; ECHINOCANDIN; PREDNISONE; VORICONAZOLE;

ANTIBODY DETECTION; ANTIGEN DETECTION; ASPERGILLUS; CHILL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG MEGADOSE; FEVER; FUNGUS CULTURE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOPATHOLOGY; INFECTION RISK; LOADING DRUG DOSE; LONG TERM CARE; LUNG ASPERGILLOSIS; MYCOSIS; OUTCOME ASSESSMENT; PNEUMONIA; RECOMMENDED DRUG DOSE; REVIEW; RIGOR; SIDE EFFECT;

EID: 77958154676     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-010-0132-1     Document Type: Review

References (62)

1. JR Perfect GM Cox JY Lee, et al. 2001 The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis Clin Infect Dis 33 1824 1833 1:STN:280:DC%2BD3MnktVGmsQ%3D%3D 10.1086/323900 11692293 (Pubitemid 33105120)
2. TJ Walsh EJ Anaissie DW Denning, et al. 2008 Treatment of Aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America Clin Infect Dis 46 327 360 1:CAS:528:DC%2BD1cXitlKqt7c%3D 10.1086/525258 18177225 (Pubitemid 351265310)
3. F Ader AL Bienvenu B Rammaert S Nseir 2009 Management of invasive aspergillosis in patients with COPD: rational use of voriconazole Int J COPD 4 279 287 1:CAS:528:DC%2BD1MXhsVCisrjN
4. W Meersseman K Lagrou J Maertens E Van Wijngaerden 2007 Invasive aspergillosis in the intensive care unit Clin Infect Dis 45 205 216 10.1086/518852 17578780 (Pubitemid 47044802)
5. KF Rabe S Hurd A Anzuet, et al. 2007 Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; GOLD executive summary Am J Respir Crit Care Med 176 532 555 10.1164/rccm.200703- 456SO 17507545 (Pubitemid 47403272)
6. KF Chung IM Adcock 2008 Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction Eur Respir J 31 1334 1356 1:CAS:528:DC%2BD1cXosVWisL8%3D 10.1183/09031936.00018908 18515558
7. S Sethi TF Murphy 2008 Infection in the pathogenesis and course of chronic obstructive pulmonary disease N Engl J Med 359 2355 2365 1:CAS:528:DC%2BD1cXhsVehtbnJ 10.1056/NEJMra0800353 19038881
8. TF Patterson WR Kirkpatrick M White, et al. 2000 Invasive aspergillosis: disease spectrum, treatment practices and outcomes Medicine 79 250 260 1:STN:280:DC%2BD3cvhsVGnsg%3D%3D 10.1097/00005792-200007000-00006 10941354 (Pubitemid 30616973)
9. SJ Lin J Schranz SM Teutsch 2001 Aspergillosis case-fatality rate: systematic review of the literature Clin Infect Dis 32 358 366 1:STN:280:DC%2BD38%2Fgs12lsg%3D%3D 10.1086/318483 11170942 (Pubitemid 32173620)
10. G Thommi G Bell J Liu K Nugent 1991 Spectrum of invasive pulmonary aspergillosis in immunocompetent patients with chronic obstructive pulmonary disease South Med J 84 828 831 1:STN:280:DyaK3M3pslGntA%3D%3D 2068622
11. J Rello ME Esandi D Mariscal, et al. 1998 Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review Clin Infect Dis 26 1473 1475 1:STN:280: DyaK1czgtVGiug%3D%3D 10.1086/517672 9636889
12. F Ader S Nseir R Le Berre, et al. 2005 Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen Clin Microbiol Infect 11 427 429 1:STN:280:DC%2BD2M3ksVamsg%3D%3D 10.1111/j.1469-0691.2005.01143.x 15882191 (Pubitemid 40744388)
13. P Bulpa A Dive Y Sibille 2007 Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease Eur Respir J 30 782 800 1:STN:280:DC%2BD2srotlKiug%3D%3D 10.1183/09031936.00062206 17906086 This study was the first to propose specific definitions of IPA in COPD patients. The "Bulpa criteria" are currently used to estimate the probability of IPA in COPD patients (Pubitemid 351194841)
14. P Samarakoon AO Soubani 2008 Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature Chron Respir Dis 5 19 27 1:STN:280:DC%2BD1c7ktlOhsQ%3D%3D 10.1177/1479972307085637 18303098 (Pubitemid 351903611)
15. X Gao L Chen G Hu H Mei 2010 Invasive pulmonary aspergillosis in acute exacerbation of chronic obstructive pulmonary disease and the diagnostic value of combined serological tests Ann Saudi Med 30 193 197 10.4103/0256-4947.62828 20427934
16. •• Guinea J, Torres-Narbona M, Gijon P, et al.: Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect 2009 (Epub ahead of print). This study presents and analyzes the largest retrospective series of COPD patients with positive Aspergillus specimens in LRT at admission who subsequently develop IPA.
17. W Meersseman SJ Vandecasteele A Wilmer, et al. 2004 Invasive aspergillosis in critically ill patients without malignancy Am J Respir Crit Care Med 170 621 625 10.1164/rccm.200401-093OC 15229094 (Pubitemid 39202203)
18. J Garnacho-Monteiro R Amaya-Villar C Ortiz-Leyba, et al. 2005 Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome Crit Care 9 R191 R199 10.1186/cc3488
19. RJ Trof A Beishuizen YJ Debets-Ossenkopp, et al. 2007 Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients Int Care Med 33 1694 1703 1:STN:280:DC%2BD2srmtlCiug%3D%3D 10.1007/s00134-007-0791-z (Pubitemid 47476659)
20. W Meersseman K Lagrou J Maertens, et al. 2008 Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients Am J Respir Crit Care Med 177 27 34 10.1164/rccm.200704-606OC 17885264
21. G Dimopoulos M Piagnerelli J Berre, et al. 2003 Disseminated aspergillosis in intensive care unit patients: an autopsy study J Chemother 15 71 75 1:STN:280:DC%2BD3s7mtFWrug%3D%3D 12678418
22. F Khasawneh T Mohamad MK Moughrabieh, et al. 2006 Isolation of Aspergillus in critically ill patients: a potential marker of poor outcome J Crit Care 21 322 327 10.1016/j.jcrc.2006.03.006 17175418 (Pubitemid 44908866)
23. B De Pauw TJ Walsh JP Donnelly, et al. 2008 Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group Clin Infect Dis 46 1813 1821 10.1086/588660 18462102
24. A Upton KA Kirby P Carpenter, et al. 2007 Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality Clin Infect Dis 44 531 540 10.1086/510592 17243056 (Pubitemid 46233255)
25. L Romani 2004 Immunity to fungal infections Nat Immunol 4 1 13 10.1038/nri1290
26. T Betsuyaku I Kuroki K Nagai, et al. 2004 Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid Eur Respir J 24 964 970 1:CAS:528:DC%2BD2MXhs1Kqsg%3D%3D 10.1183/09031936.04.00064004 15572540 (Pubitemid 39642287)
27. CS Berenson CT Wrona LJ Grove 2006 Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease Am J Respir Crit Care Med 174 31 40 1:CAS:528:DC%2BD28XntF2ltb4%3D 10.1164/rccm.200509-1461OC 16574934 (Pubitemid 43955242)
28. AS Cowburn AM Condliffe N Farahi, et al. 2008 Advances in neutrophil biology: clinical implications Chest 134 606 612 1:CAS:528:DC%2BD1cXht1Sqt7bE 10.1378/chest.08-0422 18779195
29. D Droemann T Goldmann T Tiedje, et al. 2005 Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients Respir Res 6 68 10.1186/1465-9921-6-68 16004610 (Pubitemid 41410167)
30. RE MacRedmond CM Greene DR Dorscheid, et al. 2007 Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke Respir Res 8 84 10.1186/1465-9921-8-84 18034897
31. M Chignard V Balloy JM Sallenave M Si-Tahar 2007 Role of toll-like receptors in lung innate defense against invasive aspergillosis. Distinct impact in immunocompetent and immunocompromised hosts Clin Immunol 124 238 243 1:CAS:528:DC%2BD2sXpt1eltb8%3D 10.1016/j.clim.2007.05.004 17604224 (Pubitemid 47247606)
32. A Schaffner 1985 Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon J Clin Invest 76 1755 1764 1:CAS:528:DyaL28XhsFeiuw%3D%3D 10.1172/JCI112166 3932471
33. RD Diamond 1983 Inhibition of monocyte-mediated damage to fungal hyphae by steroid hormones J Infect Dis 147 160 162 1:STN:280:DyaL3s7htVehuw%3D%3D 6822752
34. TTC Ng GD Robson DW Denning 1994 Hydrocortisone enhanced growth of Aspergillus spp.: implications for pathogenesis Microbiology 140 2475 2479 1:CAS:528:DyaK2cXmt1Kgs7w%3D 10.1099/13500872-140-9-2475 7952197
35. E Peter F Bakri DM Ball, et al. 2002 Invasive pulmonary filamentous fungal infection in a patient receiving inhaled corticosteroid therapy Clin Infect Dis 36 54 56 10.1086/341971
36. R Barouky M Badet M Saint Denis, et al. 2003 Inhaled corticosteroids in COPD and disseminated aspergillosis Eur J Int Med 14 380 382 1:CAS:528:DC%2BD3sXpvVGjsr8%3D 10.1016/S0953-6205(03)90006-9 (Pubitemid 40090264)
37. M Cornet H Hallat D Somme, et al. 2003 Fulminant invasive pulmonary aspergillosis in immunocompetent patients. A two-case report Clin Microbiol Infect 9 1224 1227 1:STN:280:DC%2BD2c%2FgvVahsg%3D%3D 10.1111/j.1469-0691.2003. 00792.x 14686988 (Pubitemid 38028873)
38. L Martinez-Solano MD Macia A Fajardo, et al. 2008 Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease Clin Infect Dis 47 1526 1533 1:CAS:528:DC%2BD1MXjs1Ohsg%3D%3D 10.1086/593186 18990062
39. MJ Seidler S Salvenmoser FMC Müller 2008 Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells Antimicrob Agents Chemother 52 4130 4136 1:CAS:528:DC%2BD1cXhtlCgs7nE 10.1128/AAC.00234-08 18710910 This is the first report of biofilm production by A. fumigatus on bronchial epithelial cells
40. IS Patel I Vlahos TM Wilkinson 2004 Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease Am J Respir Crit Care Med 170 400 407 10.1164/rccm.200305-648OC 15130905 (Pubitemid 39214614)
41. M Pihet J Carrère B Cimon, et al. 2009 Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis, a review J Med Mycol 47 387 397 10.1080/13693780802609604
42. E Jantunen A Piilonen L Volin, et al. 2000 Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients Bone Marrow Transplant 25 867 871 1:STN:280:DC%2BD3c3ntVGktw%3D%3D 10.1038/sj.bmt.1702232 10808208
43. S Andreas S Heindl C Wattky, et al. 2000 Diagnosis of pulmonary aspergillosis using optical brighteners Eur Respir J 15 407 411 1:STN:280:DC%2BD3c7mvFShuw%3D%3D 10.1034/j.1399-3003.2000.15b30.x 10706512 (Pubitemid 30085973)
44. J Maertens J Verhaegen K Lagrou, et al. 2001 Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation Blood 97 1604 1610 1:CAS:528:DC%2BD3MXitFalt70%3D 10.1182/blood.V97.6.1604 11238098 (Pubitemid 32217224)
45. CD Pfeiffer JP Fine N Safdar 2006 Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis Clin Infect Dis 42 1417 1427 1:CAS:528:DC%2BD28Xlt1Cqu74%3D 10.1086/503427 16619154
46. A Sulahian S Touratier P Ribaud 2003 False positive test for Aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam N Engl J Med 349 2366 2367 1:CAS:528:DC%2BD3sXpvVClu78%3D 10.1056/ NEJM200312113492424 14668472 (Pubitemid 37509754)
47. C Viscoli M Machetti P Cappellano, et al. 2004 False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam Clin Infect Dis 38 913 916 10.1086/382224 14999640 (Pubitemid 38387245)
48. M Sanguinetti B Posteraro L Pagano, et al. 2003 Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis J Clin Microbiol 41 3922 3925 1:CAS:528:DC%2BD3sXnt1Sktb8%3D 10.1128/JCM.41.8.3922-3925.2003 12904419 (Pubitemid 36994742)
49. B Musher D Fredricks W Leisenring, et al. 2004 Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid J Clin Microbiol 42 5517 5522 1:CAS:528:DC%2BD2MXkt12ntQ%3D%3D 10.1128/JCM.42.12.5517-5522.2004 15583275 (Pubitemid 39664330)
50. HJ Seyfarth P Nenoff J Winkler, et al. 2001 Aspergillus detection in bronchoscopically acquired material. Significance and interpretation Mycoses 44 356 360 1:STN:280:DC%2BD38%2FjvVShsg%3D%3D 10.1046/j.0933-7407.2001.93.x 11766098 (Pubitemid 34015716)
51. CJ Clancy RA Jaber HL Leather, et al. 2007 Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients J Clin Microbiol 45 1759 1765 1:CAS:528: DC%2BD2sXnsVKrtb0%3D 10.1128/JCM.00077-07 17428933 (Pubitemid 46933903)
52. W Meersseman K Lagrou J Maertens, et al. 2008 Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients Am J Respir Crit Care Med 177 27 34 10.1164/rccm.200704-606OC 17885264 This clinical study investigated GM detection in BAL fluid of ICU patients and underscored the usefulness of GM detection in establishing or excluding the diagnosis of IPA in the ICU
53. R Ansorg R Van den Boom PM Rath 1997 Detection of Aspergillus galactomannan antigen in foods and antibiotics Mycoses 40 353 357 1:CAS:528:DyaK1cXos1Cktg%3D%3D 10.1111/j.1439-0507.1997.tb00249.x 9470421
54. MJ Becker S De Marie MH Fens, et al. 2003 Effect of amphotericin B treatment on kinetics of cytokines and parameters of fungal load in neutropenic rats with invasive pulmonary aspergillosis J Antimicrob Chemother 52 428 434 1:CAS:528:DC%2BD3sXnt1Kjtbw%3D 10.1093/jac/dkg367 12917249 (Pubitemid 37120722)
55. KA Marr M Laverdiere A Gugel W Leisenring 2005 Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay Clin Infect Dis 40 1762 1769 1:CAS:528:DC%2BD2MXlsFyisLk%3D 10.1086/429921 15909264 (Pubitemid 40799945)
56. L Ostrosky-Zeichner BD Alexander DH Kett, et al. 2005 Multicenter clinical evaluation of the [1-> 3]-β-D-glucan assay as an aid to diagnosis of fungal infections in humans Clin Infect Dis 41 654 659 1:CAS:528:DC%2BD2MXhtVent7fL 10.1086/432470 16080087 (Pubitemid 41170353)
57. S Okada S Teramoto H Takizawa, et al. 2003 Clinical insignificance of [1-> 3]-β-D-glucan in early diagnosis of invasive pulmonary aspergillosis in a patient with chronic obstructive pulmonary disease J Med Microb 52 1031 1032 10.1099/jmm.0.05298-0 (Pubitemid 38648145)
58. DW Denning K Riniotis R Dobrashian H Sambatakou 2003 Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review Clin Infect Dis 37 Suppl 3 S265 S280 10.1086/376526 12975754 (Pubitemid 37260464)
59. KH Vandewoude SI Blot D Benoit, et al. 2004 Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence J Hosp Infect 56 269 276 1:STN:280: DC%2BD2c7nt12ktg%3D%3D 10.1016/j.jhin.2004.01.006 15066736 (Pubitemid 38444078)
60. RE Greene HT Schlamm JW Oestmann, et al. 2007 Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign Clin Infect Dis 44 373 379 10.1086/509917 17205443 (Pubitemid 46147619)
61. WW Hope GL Drusano 2009 Antifungal pharmacokinetics and pharmacodynamics: bridging from the bench to bedside Clin Microbiol Infect 15 602 612 1:CAS:528:DC%2BD1MXhtFWit7nI 10.1111/j.1469-0691.2009.02913.x 19673971
62. R Herbrecht DW Denning TF Patterson, et al. 2002 Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis N Engl J Med 347 408 415 1:CAS:528:DC%2BD38XlvFKrt7o%3D 10.1056/NEJMoa020191 12167683 (Pubitemid 34851833)